You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (34) |
Back to Search
Might selenium nanoparticles help as adjuvant antitumor therapy?
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-DDM-001
- By: ADAM-DIMA, Ines (Faculty of Pharmacy, University of Medicine and Pharmacy "Carol Davila" of Bucharest, Toxicology, Romania)
- Co-author(s): Ines Adam-Dima: Toxicology, "Carol Davila" University of Medicine and Pharmacy Bucharest, Bucharest, Romania
Mihaela Balas: Biochemistry and Molecular Biology, University of Bucharest, Bucharest, Romania
Carmen Nicoleta Purdel: Toxicology, "Carol Davila" University of Medicine and Pharmacy Bucharest, Bucharest, Romania
Denisa Margina: Biochemistry, "Carol Davila" University of Medicine and Pharmacy Bucharest, Bucharest, Romania - Abstract:
Background
Selenium nanoparticles (SeNPs) exhibited multiple therapeutic roles in in vitro and in vivo studies, qualifying them as a potential remedy for metabolic, cancerous or infectious diseases.
Purpose
In this study, we aimed to evaluate the biological effects of chemogenically synthesized SeNPs on two cell lines – normal (MRC-5) and malignant
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026